Pyxis Oncology Inc

-0.04 (-0.33%)
Earnings Announcements

Pyxis Reports Financial Results For The Third Quarter Of 2021 And Provides Business Update

Published: 11/15/2021 12:41 GMT
Pyxis Oncology Inc (PYXS) - Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update.
Q3 Loss per Share $8.96.
Expects Cash Position of $283 Million As of November 15, 2021 to Fund Operations Into Second Half of 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.